WIP/CIP and Closed Equipment Systems in the Field of Pharmaceutical Solid Dosage Forms

被引:0
|
作者
Schiffmann, Axel [2 ]
Luy, Bernhard
Leuenberger, Hans [2 ]
Plitzko, Matthias [1 ]
机构
[1] Glatt GmbH, Abt Neue Technol, D-79589 Binzen, Germany
[2] Univ Basel, Pharmazentrum, Basel, Switzerland
来源
PHARMAZEUTISCHE INDUSTRIE | 2009年 / 71卷 / 07期
关键词
Anlagensysteme; Containment; Cleaning in place; Feste Arzneimittelformen; Good Manufacturing Practice; Washing in place; CLEANING VALIDATION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the pharmaceutical industry production equipments for the manufacture of solid dosage forms are cleaned manually, semi- or fully-automated. In order to implement a fully automated cleaning process which meets pharmaceutical (i. e. GMP-)requirements, many conventionally used components must be changed considerably with respect to construction and design. An important aspect is the so-called Total Containment: CIP-ability and Total Containment are interdependent and must be considered equally with the development. The realisation of the Total Containment is an absolute prerequisite for the implementation of this new type of equipment. By the example of a fluid bed system this article describes, how this can be achieved by modifications of conventional equipments and of peripheral devices. The abbreviations WIP/CIP used in this context are clearly defined. WIP (washing in place) means semi- or fully-automated cleaning with either undefined result of cleaning or with the result that the system is not yet clean according to GMP-requirernents. CIP (cleaning in place), on the other hand, stands for the entire process of a fully-autornated cleaning to a GMP-conform level, including all factors, which have influence on the cleaning result. This includes the proof that the acceptance criterion of the cleaning validation was achieved. A comparison study between the manual and fully-automated cleaning shows that by systematic modification of the individual components in connection with a fully-automated cleaning program a higher cleaning grade can be achieved. Furthermore, a statement about the reproducibility of cleaning success can be met.
引用
收藏
页码:1252 / 1259
页数:8
相关论文
共 50 条
  • [11] Energy efficient smart manufacturing of pharmaceutical solid oral dosage forms
    Dan, Ashley
    Ramachandran, Rohit
    JOURNAL OF MEDICAL SCIENCE, 2023, 92 (03): : 14 - 17
  • [12] SURVIVAL OF STAPHYLOCOCCUS-AUREUS ON PHARMACEUTICAL ORAL SOLID DOSAGE FORMS
    WATERMAN, RF
    SUMNER, ED
    BALDWIN, JN
    WARREN, FW
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (08) : 1317 - 1320
  • [13] Innovative Child-Resistant Packaging for Pharmaceutical Solid Dosage Forms
    Lalji Baldaniya
    Vaibhav Shah
    Malav Maniar
    Mukesh Gohel
    Vaishali Thakkar
    Tejal Gandhi
    Journal of Packaging Technology and Research, 2019, 3 (3) : 235 - 242
  • [14] Near infrared transmittance analysis for the assay of solid pharmaceutical dosage forms
    Corti, P
    Ceramelli, G
    Dreassi, E
    Mattii, S
    ANALYST, 1999, 124 (05) : 755 - 758
  • [15] Dry coating, a novel coating technology for solid pharmaceutical dosage forms
    Luo, Yanfeng
    Zhu, Jesse
    Ma, Yingliang
    Zhang, Hui
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 358 (1-2) : 16 - 22
  • [16] Surface acidity of solid pharmaceutical excipients III. Excipients for solid dosage forms
    Scheef, CA
    Oelkrug, D
    Schmidt, PC
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 46 (02) : 209 - 213
  • [17] USE OF MICROCALORIMETRY IN THE FIELD OF PHARMACEUTICAL SCIENCES .1. MEASUREMENT OF DRUG DISSOLUTION FROM SOLID DOSAGE FORMS
    FUKUOKA, E
    MAKITA, M
    YAMAMURA, S
    YOSHIHASHI, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1994, 42 (10) : 2139 - 2142
  • [18] PHARMACEUTICAL HETEROGENEOUS SYSTEMS .4. A KINETIC APPROACH TO STABILITY SCREENING OF SOLID DOSAGE FORMS CONTAINING ASPIRIN
    MAULDING, HV
    ZOGLIO, MA
    PIGOIS, FE
    WAGNER, M
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (11) : 1359 - &
  • [19] Use of oxygen scavengers to stabilize solid pharmaceutical dosage forms: A case study
    Waterman, KC
    Roy, MC
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2002, 7 (02) : 227 - 234
  • [20] Pharmaceutical compatibility of dexamethasone with excipients commonly used in solid oral dosage forms
    Santos, Widson M.
    Nobrega, Fernanda P.
    Andrade, Jessica C.
    Almeida, Lucas F.
    Conceicao, Marta M.
    Medeiros, Ana Claudia D.
    Medeiros, Francinalva D.
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2021, 145 (02) : 361 - 378